Trial intelligence / Profile preview

Oxidative stress during modified radical mastectomy under sevoflurane versus total intravenous anesthesia

PACTR201604001579155Recruiting

Sponsor
Mohamed M Abu Elyazed
Start
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of sevoflurane and propofol + remifentanil in breast cancer (2 arms), sponsored by Mohamed M Abu Elyazed. Primary endpoint: serum nitric oxide. Started Feb 2016; status: recruiting.

02

Drugs

sevofluranepropofol + remifentanil
03

Conditions

breast cancer

Beyond the preview

Go deeper on PACTR201604001579155.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201604001579155.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call